文献速递帕金森病与运动障碍脑血管病

遗传性血色病相关基因变异与脑磁共振成像铁沉积及运动障碍的关联

Association of Genetic Variant Linked to Hemochromatosis With Brain Magnetic Resonance Imaging Measures of Iron and Movement Disorders.
PubMed 文献 · JAMA Neurol · 2022-01-01

这项基于英国生物样本库的横断面回顾性研究纳入488288人,其中2889人为p.C282Y纯合子。神经影像分析显示p.C282Y纯合子皮层下运动结构T2加权和T2*信号强度降低(Cohen d>1)。在全队列中,男性纯合子运动障碍患病率显著升高(OR 1.80,95%CI 1.28-2.55,P=0.001),女性无显著差异(OR 1.09,95%CI 0.70-1.73,P=0.69)。

要点

  • p.C282Y纯合子与皮层下运动结构铁沉积相关,T2/T2*信号降低(Cohen d>1)。
  • 男性纯合子运动障碍患病风险升高(OR 1.80,95%CI 1.28-2.55,P=0.001)。
  • 女性纯合子运动障碍风险无显著升高(OR 1.09,95%CI 0.70-1.73,P=0.69)。

核心结论

  • p.C282Y纯合子存在皮层下运动环路铁沉积增加,并证实男性纯合子与运动障碍的关联增强。
  • 作者认为,在高危个体中筛查p.C282Y纯合子可能减少脑铁蓄积并降低男性纯合子运动障碍风险。

研究设计与样本

  • 横断面回顾性研究,使用英国生物样本库人群样本,收集2006年1月至2021年5月的基因型、健康记录和神经影像数据。
  • 总队列488288人(女性264719人;年龄49-87岁,主要为北欧血统),其中2889人为p.C282Y纯合子。
  • 神经影像分析纳入836人:165例p.C282Y纯合子(女性99例)和671例匹配对照(女性399例);206人因撤回同意被排除。

主要发现

  • 神经影像分析显示,p.C282Y纯合子与皮层下运动结构(基底节、丘脑、红核和小脑)T2加权和T2*信号强度降低相关(Cohen d>1),符合明显铁沉积。
  • 全生物样本库分析(2889例p.C282Y纯合子,485399例对照)显示,男性纯合子运动障碍患病率显著升高(OR 1.80,95%CI 1.28-2.55,P=0.001)。
  • 女性纯合子运动障碍患病率无显著升高(OR 1.09,95%CI 0.70-1.73,P=0.69)。
  • 31例伴有运动障碍的男性p.C282Y纯合子中,仅10例同时有遗传性血色病诊断。

临床怎么用

  • 作者认为,在高危个体中筛查p.C282Y纯合子可能减少脑铁蓄积并降低男性纯合子运动障碍风险。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Hereditary hemochromatosis (HH) is an autosomal recessive genetic disorder that leads to iron overload. Conflicting results from previous research has led some to believe the brain is spared the toxic effects of iron in HH. OBJECTIVE: To test the association of the strongest genetic risk variant for HH on brainwide measures sensitive to iron deposition and the rates of movement disorders in a substantially larger sample than previous studies of its kind. DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional retrospective study included participants from the UK Biobank, a population-based sample. Genotype, health record, and neuroimaging data were collected from January 2006 to May 2021. Data analysis was conducted from January 2021 to April 2022. Disorders tested included movement disorders (International Statistical Classification of Diseases and Related Health Problems, Tenth Revision [ICD-10], codes G20-G26), abnormalities of gait and mobility (ICD-10 codes R26), and other disorders of the nervous system (ICD-10 codes G90-G99). EXPOSURES: Homozygosity for p.C282Y, the largest known genetic risk factor for HH. MAIN OUTCOMES AND MEASURES: T2-weighted and T2* signal intensity from brain magnetic resonance imaging scans, measures sensitive to iron deposition, and clinical diagnosis of neurological disorders. RESULTS: The total cohort consisted of 488 288 individuals (264 719 female; ages 49-87 years, largely northern European ancestry), 2889 of whom were p.C282Y homozygotes. The neuroimaging analysis consisted of 836 individuals: 165 p.C282Y homozygotes (99 female) and 671 matched controls (399 female). A total of 206 individuals were excluded from analysis due to withdrawal of consent. Neuroimaging analysis showed that p.C282Y homozygosity was associated with decreased T2-weighted and T2* signal intensity in subcortical motor structures (basal ganglia, thalamus, red nucleus, and cerebellum; Cohen d >1) consistent with substantial iron deposition. Across the whole UK Biobank (2889 p.C282Y homozygotes, 485 399 controls), we found a significantly increased prevalence for movement disorders in male homozygotes (OR, 1.80; 95% CI, 1.28-2.55; P = .001) but not female individuals (OR, 1.09; 95% CI, 0.70-1.73; P = .69). Among the 31 p.C282Y male homozygotes with a movement disorder, only 10 had a concurrent HH diagnosis. CONCLUSIONS AND RELEVANCE: These findings indicate increased iron deposition in subcortical motor circuits in p.C282Y homozygotes and confirm an increased association with movement disorders in male homozygotes. Early treatment in HH effectively prevents the negative consequences of iron overload in the liver and heart. Our work suggests that screening for p.C282Y homozygosity in high-risk individuals also has the potential to reduce brain iron accumulation and to reduce the risk of movement disorders among male individuals who are homozygous for this mutation.

来源:JAMA Neurol,查看原文。版权归原作者所有。

引用

  1. Loughnan R, Ahern J, Tompkins C, et al. Association of Genetic Variant Linked to Hemochromatosis With Brain Magnetic Resonance Imaging Measures of Iron and Movement Disorders. JAMA Neurol. 2022. PMID: 35913729. doi:10.1001/jamaneurol.2022.2030

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。